Strategy Pref A 8.00% triggers RSI Oversold, KDJ Golden Cross on 15min chart.

The 15-minute chart for Strategy Pref A 8.00% triggered a reading of RSI Oversold and KDJ Golden Cross at 10:15 on October 10, 2025. This indicates that the stock price has experienced a significant decline, falling below its fundamental support level. However, the momentum of the stock price is shifting towards an upward trajectory, suggesting that there is potential for further price appreciation.

Aptorum Group Limited (NASDAQ: APM) experienced a significant drop in its stock price following the announcement of a registered direct offering and a concurrent private placement to raise $2 million. The biopharmaceutical company revealed it has entered into definitive agreements to sell 1,000,000 Class A ordinary shares at $2.00 per share. Additionally, Aptorum will issue unregistered warrants to purchase up to 2,000,000 Class A ordinary shares at an exercise price of $2.00 per share, exercisable upon issuance with a 24-month expiration period Aptorum Group stock falls after $2 million direct offering^[1].

H.C. Wainwright & Co. is serving as the exclusive placement agent for the offering, which is expected to close around October 14, 2025, subject to customary closing conditions. The proceeds from the offering will be used to fund expenses related to Aptorum's previously announced merger agreement with DiamiR Biosciences Corp. and for general working capital of both companies pending the merger’s anticipated closing. The merger remains contingent on several factors, including approval by Aptorum’s shareholders Aptorum Group stock falls after $2 million direct offering^[1].

The stock tumbled 23% following the announcement, indicating investor concerns about the dilution of shares and the potential impact on the company's financial health. The unregistered warrants, if fully exercised on a cash basis, could provide additional gross proceeds of $4 million, but there is no assurance that any warrants will be exercised Aptorum Group stock falls after $2 million direct offering^[1].

Investors should closely monitor the development of the merger agreement and the potential impact of the direct offering and private placement on Aptorum's financial position. The company's ability to successfully complete the merger and manage its financial obligations will be critical to its future performance.